RESUMEN
Only time will tell if serotonergic hallucinogen-assisted psychotherapy treatment paradigms for SUDs will prove to be safe and effective in double-blind, placebo-controlled clinical trials. If they are, they would truly constitute a novel psychopharmacologic-psychosocial treatment paradigm to treat addictive disorders, although the risk of adverse psychological events would have to be controlled through a careful screening process and the risk of misuse of the substances or developing use syndromes would have to be considered, although the overall risk would be low because, as mentioned, SHs are unlike all other drugs of abuse in that they do not appear to produce dependence syndromes. There effects on the NA and DA range from inhibition to slight activation, all this without producing addiction. The ability of these medicinal tools to treat a range of addictive, psychiatric, and existential disorders is remarkable in scope and possibility. They truly represent a potential paradigmatic shift within the field of psychiatry, too interesting to not explore further.
Asunto(s)
Conducta Adictiva/tratamiento farmacológico , Alucinógenos/farmacología , Fitoterapia , Agonistas del Receptor de Serotonina 5-HT2/farmacología , Síndrome de Abstinencia a Sustancias/prevención & control , Trastornos Relacionados con Sustancias/tratamiento farmacológico , Adulto , Animales , Conducta Adictiva/metabolismo , Conducta Adictiva/fisiopatología , Ensayos Clínicos como Asunto , Cognición/efectos de los fármacos , Dopamina/metabolismo , Agonistas de Dopamina/farmacología , Glutamatos/metabolismo , Alucinógenos/química , Alucinógenos/clasificación , Humanos , Ibogaína/farmacología , Ácido Lisérgico/farmacología , Plasticidad Neuronal/efectos de los fármacos , Núcleo Accumbens/metabolismo , Corteza Prefrontal/efectos de los fármacos , Corteza Prefrontal/metabolismo , Corteza Prefrontal/fisiopatología , Psilocibina/farmacología , Religión , Recompensa , Agonistas del Receptor de Serotonina 5-HT2/química , Agonistas del Receptor de Serotonina 5-HT2/clasificación , Trastornos Relacionados con Sustancias/metabolismo , Trastornos Relacionados con Sustancias/fisiopatologíaRESUMEN
BACKGROUND: A plant with dissociative and psychoactive properties began to attract the attention of the media and United States policymakers following a well-publicized suicide in 2006 and reports that the plant served as a 'legal high' and substitute for cannabis. As a result, Salvia divinorum and its active ingredient, salvinorin A, were classified as Schedule I substances by the Florida Legislature on July 1, 2008. As of yet, no research has explored the efficacy of this policy or similar policies in other jurisdictions. METHODS: Three self-report studies collected from young adults both prior to and following the policy's implementation are employed to investigate the potential relationship between the policy and usage rates. In addition, law enforcement personnel from the state's most populated areas were interviewed to determine the extent to which they were encountering salvia in their work. RESULTS: It was indicated that less than two-thirds of those surveyed were aware of the drug's legal status. Lifetime prevalence of salvia use was largely unchanged. However, the rates of self-reported past year and past month use in Florida were significantly lower following the scheduling. Though use of Salvia divinorum appears to have decreased, perceptions of peer use increased markedly. Law enforcement officers and laboratories reported rarely, if ever, dealing with cases of salvia possession. CONCLUSIONS: Data suggests the classification of Salvia divinorum as a Schedule I drug was followed by a substantial reduction in recreational use. We caution that other factors may have influenced use, that the efficacy of scheduling novel substances is likely to vary by drug type, that such a reduction in reported use may only exist transiently until a sophisticated illicit market develops to replace the legitimate one, and that a state's success in regulating salvia may be related to their regulation of and enforcement of other drug prohibitions.
Asunto(s)
Crimen/legislación & jurisprudencia , Diterpenos de Tipo Clerodano/provisión & distribución , Control de Medicamentos y Narcóticos/legislación & jurisprudencia , Alucinógenos/provisión & distribución , Drogas Ilícitas/legislación & jurisprudencia , Drogas Ilícitas/provisión & distribución , Extractos Vegetales/provisión & distribución , Política Pública/legislación & jurisprudencia , Salvia , Concienciación , Crimen/prevención & control , Recolección de Datos , Diterpenos de Tipo Clerodano/clasificación , Femenino , Florida , Regulación Gubernamental , Alucinógenos/clasificación , Conductas Relacionadas con la Salud , Conocimientos, Actitudes y Práctica en Salud , Humanos , Drogas Ilícitas/clasificación , Aplicación de la Ley , Masculino , Percepción , Extractos Vegetales/clasificación , Evaluación de Programas y Proyectos de Salud , Trastornos Relacionados con Sustancias/prevención & controlRESUMEN
Data mining is a powerful bioinformatics strategy that has been successfully applied in vitro to screen for gene-expression profiles predicting toxicological or carcinogenic response ('class predictors'). In this report we used a data mining algorithm named Pattern Array (PA) in vivo to analyze mouse open-field behavior and characterize the psychopharmacological effects of three drug classes--psychomotor stimulant, opioid, and psychotomimetic. PA represents rodent movement with approximately 100,000 complex patterns, defined as multiple combinations of several ethologically relevant variables, and mines them for those that maximize any effect of interest, such as the difference between drug classes. We show that PA can discover behavioral predictors of all three drug classes, thus developing a reliable drug-classification scheme in small group sizes. The discovered predictors showed orderly dose dependency despite being explicitly mined only for class differences, with the high doses scoring 4-10 standard deviations from the vehicle group. Furthermore, these predictors correctly classified in a dose-dependent manner four 'unknown' drugs (ie that were not used in the training process), and scored a mixture of a psychomotor stimulant and an opioid as being intermediate between these two classes. The isolated behaviors were highly heritable (h(2)>50%) and replicable as determined in 10 inbred strains across three laboratories. PA can in principle be applied for mining behaviors predicting additional properties, such as within-class differences between drugs and within-drug dose-response, all of which can be measured automatically in a single session per animal in an open-field arena, suggesting a high potential as a tool in psychotherapeutic drug discovery.
Asunto(s)
Analgésicos Opioides/clasificación , Estimulantes del Sistema Nervioso Central/clasificación , Descubrimiento de Drogas/métodos , Alucinógenos/clasificación , Informática Médica/métodos , Movimiento/efectos de los fármacos , Algoritmos , Analgésicos Opioides/farmacología , Animales , Relación Dosis-Respuesta a Droga , Evaluación Preclínica de Medicamentos/métodos , Alucinógenos/farmacología , Masculino , Ratones , Ratones Endogámicos C57BL , Ratones Endogámicos , Modelos Animales , Reconocimiento de Normas Patrones Automatizadas , Carácter Cuantitativo HeredableRESUMEN
Some herbal products are emerging as popular drugs for recreational abuse. Plant and herbal supplements used recreationally can have a wide spectrum of clinical effects ranging from euphoric and stimulant effects to hallucinogenic experiences. Despite the potential for abuse, addiction, and serious adverse effects, there may be a false perception that these products are all safe, legal, and organic. These perceptions and the ease of accessibility to herbal products could result in greater potential for recreational abuse and subsequent complications presenting to emergency departments. Health care professionals must be cognizant of this emerging problem as increased media coverage and marketing have made these products accessible and recognizable to many young adults and teenagers.
Asunto(s)
Analgésicos/efectos adversos , Alucinógenos/efectos adversos , Preparaciones de Plantas/efectos adversos , Trastornos Relacionados con Sustancias/fisiopatología , Simpatomiméticos/efectos adversos , Adolescente , Adulto , Alucinógenos/clasificación , Humanos , Preparaciones de Plantas/clasificación , Trastornos Relacionados con Sustancias/epidemiología , Trastornos Relacionados con Sustancias/terapia , Simpatomiméticos/clasificación , Estados Unidos/epidemiologíaRESUMEN
Atualmente, um crescente interesse nas praticas rituais indigenas, as quais se utilizavam de plantas com o intuito de se comunicarem com o mundo espiritual tem sido observado. No Brasil, as ceitas religiosas Uniao do Vegetal (UDV) e Santo Daime, frequentemente, fazem uso do cha, preparado a partir das plantas Banisteriopsis caap e Psychotria viridis...